Pharma BD Deal Intelligence
Outcome grade pending — assessed 5 years post-close.
Full analysis, sources & comparables →Teva paid $86 million (€97 million) for Bayer Classics, which was the third-largest supplier of generics to the French retail market. Half-year sales ending…
Teva purchased the French generics division of Bayer Pharma AG and Honeywell's subsidiary Honeywell Pharmaceutical Fine Chemicals, with production facilities…
Teva Pharmaceutical Industries plans thousands of layoffs in the U.S. amid debt crisis; the company accrued mountains of debt as a result of the 2016 Actavis…
Source summaries from our enrichment pipeline; follow links for originals.
All 5 sources with sentiment breakdown →
July 2002 acquisition of Bayer's French generics arm (3rd largest generic in France); renamed Teva Classics.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd. / Bayer Classics (Bayer Pharma S.A. French generics division) (this deal) | 2002 | $86M | — |
| Teva Pharmaceutical Industries Ltd. / Auspex Pharmaceuticals | 2015 | $3.5B | 86 |
| Teva Pharmaceutical Industries Ltd. / Biogal Pharmaceutical | 1995 | — | 82 |
| Teva Pharmaceutical Industries Ltd. / Sicor Inc. | 2003 | $3.4B | 68 |
| Teva Pharmaceutical Industries Ltd. / Ivax Corporation | 2006 | $7.4B | 63 |
| Teva Pharmaceutical Industries Ltd. / Novopharm Limited | 2000 | $600M | 62 |
| Teva Pharmaceutical Industries Ltd. / Ivax Corporation | 2005 | $7.4B | 62 |
← Browse all deals · How we score deals
More: 2002 deals · Teva Pharmaceutical Industries Ltd. deals